Furthermore, we confirmed that PTEN expression decreases CAV1/BCAT immuno-complex in murine tumour samples and affects the transcription of known β-catenin targets, MYC and CCDN1 (Fig. 7d,e). This evidence concerns the gene PTEN and neoplasm.